Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A Mudd

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
JCI Insight|July 21, 2020
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infectionsKenneth E Remy, Monty Mazer, David A Striker, et al.
Nature|October 2, 2012
Vaccine-induced CD8+ T cells control AIDS virus replicationPhilip A Mudd, Mauricio A Martins, Adam J Ericsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 13, 2020
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14Bruce K Patterson, Harish Seethamraju, Kush Dhody, et al.
Cell|January 13, 2022
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansPhilip A Mudd, Anastasia A Minervina, Mikhail V Pogorelyy, et al.
Frontiers in Immunology|January 9, 2023
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patientsFrank J Lin, Alexa Michelle Altman Doss, Hannah G Davis-Adams, et al.
The Journal of Infectious Diseases|March 5, 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Chest|July 13, 2026
The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness SyndromesWesley H Self, Carolyn S Calfee, Samuel M Brown, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
JCI Insight|July 21, 2020
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infectionsKenneth E Remy, Monty Mazer, David A Striker, et al.
Nature|October 2, 2012
Vaccine-induced CD8+ T cells control AIDS virus replicationPhilip A Mudd, Mauricio A Martins, Adam J Ericsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 13, 2020
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14Bruce K Patterson, Harish Seethamraju, Kush Dhody, et al.
Cell|January 13, 2022
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansPhilip A Mudd, Anastasia A Minervina, Mikhail V Pogorelyy, et al.
Frontiers in Immunology|January 9, 2023
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patientsFrank J Lin, Alexa Michelle Altman Doss, Hannah G Davis-Adams, et al.
The Journal of Infectious Diseases|March 5, 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Chest|July 13, 2026
The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness SyndromesWesley H Self, Carolyn S Calfee, Samuel M Brown, et al.
Pageof 6